All Stories

  1. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System

    Article • Expert Opinion on Drug Safety, August 2018, Taylor & Francis

    Dr Kjetil Bjørnevik, Fabrizio De Ponti

  2. Polyunsaturated fatty acids and the risk of multiple sclerosis

    Article • Multiple Sclerosis Journal, February 2017, SAGE Publications

    Dr Kjetil Bjørnevik

  3. Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study

    Article • Multiple Sclerosis Journal, September 2016, SAGE Publications

    Dr Kjetil Bjørnevik

  4. Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Dr Kjetil Bjørnevik

  5. Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study

    Article • Multiple Sclerosis Journal, May 2015, SAGE Publications

    Dr Kjetil Bjørnevik

  6. Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study

    Article • Multiple Sclerosis Journal, January 2014, SAGE Publications

    Dr Kjetil Bjørnevik